t
BATM Advanced Communications Limited announced that all resolutions were passed at its Annual General Meeting held on 10 December 2025. Leor Miles, Gil Sharon, and Ayala Hakim were appointed as directors, while Dr. Zvi Marom stood down from the Board, effective from the conclusion of the meeting. Among the passed resolutions was a special resolution approving the sale of its subsidiary, AMS, to Dr. Zvi Marom.
| Date | 10 Dec 2025 |
| Time | 12:00:00 |
| Category | AGMs and other meetings |
| ID | 0419L |
LEI: 213800FLQUB9J289RU66
10 December 2025
BATM Advanced Communications Limited
("BATM" or "the Group")
Result of AGM, Directorate Change and Update on Sale of AMS
BATM (LSE: BVC; TASE: BVC), a global provider of advanced network infrastructure, cybersecurity and diagnostic technologies, announces that at its Annual General Meeting ("AGM" or the "Meeting"), held earlier today, all resolutions were duly passed. This includes the resolutions appointing Leor ("Lior") Miles as an Executive Director, Gil Sharon as a Non-executive Director and Ayala Hakim as an External Director, as defined under Israeli law, of the Group with effect from the conclusion of the Meeting.
In addition, further to the announcement of 5 November 2025, the Group confirms that Dr. Zvi Marom stood down from the Board of Directors at the conclusion of the Meeting.
Details of the voting results, which should be read alongside the Notice of AGM, are below:
|
Resolution |
Votes for |
Votes against |
Votes withheld |
Total votes cast |
||
|
|
No. of votes |
% of votes cast* |
No. of votes |
% of votes cast* |
No. of votes |
|
|
1 |
275,600,298 |
98.05 |
5,481,249 |
1.95 |
0 |
281,081,547 |
|
2 |
275,518,350 |
98.02 |
5,563,197 |
1.98 |
0 |
281,081,547 |
|
3 |
259,534,191 |
96.66 |
8,969,888 |
3.34 |
12,577,468 |
281,081,547 |
|
4 |
180,028,192 |
95.28 |
8,926,907 |
4.72 |
81,948 |
189,037,047** |
|
5 |
167,478,993 |
88.60 |
21,554,304 |
11.40 |
92,048,250 |
281,081,547 |
|
6 |
179,981,461 |
95.21 |
9,051,836 |
4.79 |
92,048,250 |
281,081,547 |
|
7 |
188,873,068 |
99.92 |
160,229 |
0.08 |
92,048,250 |
281,081,547 |
|
8 |
180,056,461 |
95.25 |
8,976,836 |
4.75 |
92,048,250 |
281,081,547 |
|
9 |
180,056,461 |
95.25 |
8,976,836 |
4.75 |
92,048,250 |
281,081,547 |
|
10 |
179,981,461 |
95.21 |
9,051,836 |
4.79 |
92,048,250 |
281,081,547 |
|
11 |
188,873,068 |
99.95 |
85,229 |
0.05 |
92,123,250 |
281,081,547 |
|
12 |
179,703,555 |
95.10 |
9,258,492 |
4.90 |
92,119,500 |
281,081,547 |
*Excludes withheld votes.
** As noted in the Group's announcement of 5 November 2025, Dr. Marom did not vote on this resolution.
There were no discretionary votes cast.
Other than the below, there are no other required disclosures pursuant to UK Listing Rule 6.4.8 in relation to Lior Miles, Gil Sharon and Ayala Hakim:
|
|
Current directorships held in public companies |
Directorships in public companies held within the past five years |
|
Gil Sharon |
N/A |
Bezeq The Israeli Telecommunications Corporation Ltd. |
In accordance with UK Listing Rule 6.4.2, a copy of the resolutions, other than resolutions concerning ordinary business, has been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism
Update on Sale of AMS
Among the resolutions passed at the AGM was a special resolution approving the sale of A.M.S 2000 Trading Impex SRL ("AMS"), a subsidiary of the Group that distributes diagnostic laboratory equipment in Romania, to Dr. Zvi Marom. The parties will now proceed to satisfy all outstanding legal and regulatory requirements, with the completion of the sale of AMS expected in the near term. The Group will issue a further announcement in due course.
Enquiries
|
BATM |
|
|
Moti Nagar, Chief Executive Officer |
+972 9866 2525 |
|
Lior Miles, Chief Financial Officer |
|
|
|
|
|
Shore Capital |
|
|
Mark Percy, Anita Ghanekar, James Thomas (Corporate Advisory) |
+44 20 7408 4050 |
|
|
|
|
Gracechurch Group |
|
|
Harry Chathli, Claire Norbury |
+44 20 4582 3500 |
|
|
|
|
KK Advisory |
|
|
Kam Bansil, Steve Keeling |
+44 20 7039 1901 |
Forward-looking statements
This document contains forward-looking statements. Those statements reflect the current opinions, evaluations and estimations of the Group's management, and are based on the current data regarding the Group's business as is detailed in this document and in the Group's periodical, interim and immediate reports. The Group does not undertake any obligation or make any representation that actual results and events will be in line with those statements, and stresses that they may differ materially from those statements, due to changes in the Group's business, market, competition, demand for the Group's products or services, general economic factors or other factors that can influence the Group's business and results, due to the risk factors that are detailed in the Group's Annual Report, and due to information and factors that are currently unknown to the Group's management and that, if known, would affect the management's opinions, evaluations or estimations. The Group will report the actual results and events according to its legal, accounting and regulatory obligations, and does not undertake any other obligation to report them or their deviations from the forward-looking statements, or to update any of the forward-looking statements in this document or to report that it is not valid anymore.